A phase II trial of trastuzumab (H) + capecitabine (X) as first-line treatment in patients (pts) with HER2-positive metastatic breast cancer (MBC) Liming Xu,Shuxian Song,Jianxi Zhu,Rong Luo,Liming Li, Shi Jiao,Ly Chen,Meixia Tao,Yining Su,Deming LiuANNALS OF ONCOLOGY（2006）引用 44|浏览6暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
